Dr. Cui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3801 Filbert St
Philadelphia, PA 19104Phone+1 215-662-8100Fax+1 484-434-2793
Summary
- Dr. Qi Cui is an ophthalmologist and glaucoma researcher in Philadelphia, PA and is affiliated with Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center. She received her medical degree and PhD from the University of Rochester School of Medicine and Dentistry and has been in practice for 8 years. She specializes in glaucoma and is experienced in glaucoma and related disorders, cataract surgery, and minimally invasive cataract surgery. She is fluent in Chinese (Mandarin).
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Glaucoma, 2015 - 2016
University of California (San Francisco)Residency, Ophthalmology, 2012 - 2015
UPMC Medical EducationInternship, Transitional Year, 2011 - 2012
University of Rochester School of Medicine and DentistryClass of 2011
Certifications & Licensure
CA State Medical License 2013 - Present
PA State Medical License 2015 - 2024- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- AGS Young Clinician Scientist Award American Glaucoma Society, 2018
- Heed Ophthalmic Fellowship Heed Foundation, 2015-2016
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- 18 citationsRepeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use.Qi N. Cui, Iga N. Gray, Yinxi Yu, Brian L VanderBeek
Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2019-05-31 - 23 citationsGlucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucomaJacob Sterling, Peiying Hua, Joshua L. Dunaief, Qi N. Cui, Brian L VanderBeek
The British Journal of Ophthalmology. 2021-08-19 - 32 citationsThe role of glia in the physiology and pharmacology of glucagon-like peptide-1: implications for obesity, diabetes, neurodegeneration and glaucoma.Qi N. Cui, Lauren M. Stein, Samantha M. Fortin, Matthew R. Hayes
British Journal of Pharmacology. 2021-09-14
Press Mentions
GLP-1R Agonists Appear to Lower Glaucoma Risk in T2D PatientsSeptember 29th, 2021
Correcting a Blind SpotJune 30th, 2018
Grant Support
- Mitochondrial Respiratory Chain Dysfunction in Primary Open Angle GlaucomaNIH-NEI2019–Present
- PENN Vision Clinical Scientist Program K12 (PI: Maureen Maguire)NIH-NEI2016–2019
- Auditory And Visual Integration And PlasticityNational Institute On Deafness And Other Communication Disorders2007–2010
Professional Memberships
- Fellow
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
